Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Rinaldi

Showing results (201-210 of 231) with videos related to

Pageof 24
Sort By:
Reviews in Cardiovascular Medicine|December 8, 2025
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging ParadigmAlfredo Caturano, Davide Nilo, Giovanni Di Lorenzo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 31, 2021
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetesFerdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2022
Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized StudyAldo Marrone, Riccardo Nevola, Ausilia Sellitto, et al.
International Journal of Molecular Sciences|April 28, 2023
HBV Infection and Host Interactions: The Role in Viral Persistence and OncogenesisRiccardo Nevola, Domenico Beccia, Valerio Rosato, et al.
Diabetes, Obesity & Metabolism|August 8, 2020
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective studyLuigi E Adinolfi, Salvatore Petta, Anna L Fracanzani, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia ManagementMarina Lugarà, Stefania Tamburrini, Maria Gabriella Coppola, et al.
Biology|July 29, 2023
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular CarcinomaRiccardo Nevola, Giovanni Tortorella, Valerio Rosato, et al.
Atherosclerosis|February 1, 2020
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre studyLuigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani, et al.
Journal of Viral Hepatitis|September 28, 2021
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective studyValerio Rosato, Antonio Ascione, Riccardo Nevola, et al.
Journal of Hepatology|March 6, 2018
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosisSalvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani, et al.
Pageof 24

Showing results (201-210 of 231) with videos related to

Sort By:
Pageof 24
Reviews in Cardiovascular Medicine|December 8, 2025
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging ParadigmAlfredo Caturano, Davide Nilo, Giovanni Di Lorenzo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 31, 2021
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetesFerdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2022
Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized StudyAldo Marrone, Riccardo Nevola, Ausilia Sellitto, et al.
International Journal of Molecular Sciences|April 28, 2023
HBV Infection and Host Interactions: The Role in Viral Persistence and OncogenesisRiccardo Nevola, Domenico Beccia, Valerio Rosato, et al.
Diabetes, Obesity & Metabolism|August 8, 2020
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective studyLuigi E Adinolfi, Salvatore Petta, Anna L Fracanzani, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia ManagementMarina Lugarà, Stefania Tamburrini, Maria Gabriella Coppola, et al.
Biology|July 29, 2023
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular CarcinomaRiccardo Nevola, Giovanni Tortorella, Valerio Rosato, et al.
Atherosclerosis|February 1, 2020
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre studyLuigi Elio Adinolfi, Salvatore Petta, Anna Ludovica Fracanzani, et al.
Journal of Viral Hepatitis|September 28, 2021
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective studyValerio Rosato, Antonio Ascione, Riccardo Nevola, et al.
Journal of Hepatology|March 6, 2018
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosisSalvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani, et al.
Pageof 24